Novus Therapeutics Inc. (NVUS) Gained 26.51% or 0.57 To Price $2.74 On Tuesday


Novus Therapeutics Inc. (NVUS) gained 26.51% or 0.57 to $2.74. It is approximately 44101 shares traded, which is 130.37% compare to the average total volume 33827. The market cap of NVUS is $25.79 million. The year to date change is 56.84%. The 52 week price range is from $1.52 to $8.61. Price of NVUS have changed -5.93% during last week. It have changed -29.30% over last month, -50.61% over last 3 months, -68.87% over last 6 months and -43.51% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVUS is 2.98. It is 8.76% above current price. The 200-day Moving Averages for NVUS is 4.82. It is 75.91% above current price. The 52-week High is 8.61. It is 214.23% from the current price. The 52-week Low is 1.52. It is -44.53% from current price.

There are some statistics of NVUS. It is has market cap $25.79 million. The share outstanding is 9.42 million. The average volume is 33827. The percent of top 15 Institution holding is 41.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVUS is -47.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVUS is -43.14%.


Tags:

Share this post